19 results match your criteria: "University of Pittsburgh School of Medicine and Western Psychiatric Institute and Clinic[Affiliation]"

Co-use of cannabis and tobacco is increasingly common among women and is associated with tobacco and cannabis dependence and poorer cessation outcomes. However, no study has examined maternal patterns of co-use over time, or the impact of maternal co-use on co-use and drug problems in adult offspring. Pregnant women (M age = 23, range = 18-42; 52% African American, 48% White) were asked about substance use during each trimester of pregnancy, and at 8 and 18 months, 3, 6, 10, 14, 16, and 22 years postpartum.

View Article and Find Full Text PDF

Introduction: Prenatal exposures to tobacco and cannabis are associated with combustible cigarette use. This study evaluated pathways from these prenatal exposures to adult electronic cigarette use. We tested whether there were indirect effects of these prenatal exposures via childhood behavior dysregulation, early tobacco use, and adolescent tobacco dependence.

View Article and Find Full Text PDF

Objective: Research in individuals with bulimia nervosa has highlighted the clinical significance of weight suppression (WS), defined as the difference between one's highest and current weight. More recently, studies have suggested that WS also may play a role in symptom maintenance and weight gain during treatment in anorexia nervosa (AN) and that the influence of WS on AN outcomes may depend on an individual's body mass index (BMI). However, no study has investigated whether WS or the interaction between WS and BMI is associated with the longer-term course of eating pathology following treatment discharge in patients with AN.

View Article and Find Full Text PDF

Objective: This quality improvement program evaluation investigated the effectiveness of contingency management for improving retention in treatment and positive outcomes among patients with dual disorders in intensive outpatient treatment for addiction.

Methods: The effect of contingency management was explored among a group of 160 patients exposed to contingency management (n = 88) and not exposed to contingency management (no contingency management, n = 72) in a six-week partial hospitalization program. Patients referred to the partial hospitalization program for treatment of substance use and comorbid psychiatric disorders received diagnoses from psychiatrists and specialist clinicians according to the Diagnostic and Statistical Manual of the American Psychiatric Association.

View Article and Find Full Text PDF

Cognitive impairment is highly prevalent among individuals with late-life depression (LLD) and tends to persist even after successful treatment. The biological mechanisms underlying cognitive impairment in LLD are complex and likely involve abnormalities in multiple pathways, or 'cascades,' reflected in specific biomarkers. Our aim was to evaluate peripheral (blood-based) evidence for biological pathways associated with cognitive impairment in older adults with LLD.

View Article and Find Full Text PDF

A proposal for an updated neuropsychopharmacological nomenclature.

Eur Neuropsychopharmacol

July 2014

Department of Psychiatry, University of California San Diego, San Diego, CA, USA; Department of Psychiatry, University of Cambridge, United Kingdom.

Current psychopharmacological nomenclature remains wedded in an earlier period of scientific understanding, failing to reflect contemporary developments and knowledge, does not aid clinicians in selecting the best medication for a given patient, and tends to confuse patients by prescribing a drug that does not reflect their identified diagnosis (e.g. prescribe "antipsychotics" to depression).

View Article and Find Full Text PDF

Because the integration of mental or behavioral health services in pediatric primary care is a national priority, a description and evaluation of the interventions applied in the healthcare setting is warranted. This article examines several intervention research studies based on alternative models for delivering behavioral health care in conjunction with comprehensive pediatric care. This review describes the diverse methods applied to different clinical problems, such as brief mental health skills, clinical guidelines, and evidence-based practices, and the empirical outcomes of this research literature.

View Article and Find Full Text PDF

The clinical utility of personality subtypes in patients with anorexia nervosa.

J Consult Clin Psychol

October 2011

Department of Psychiatry, University of Pittsburgh School of Medicine and Western Psychiatric Institute and Clinic, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA.

Objective: Elucidation of clinically relevant subtypes has been proposed as a means of advancing treatment research, but classifying anorexia nervosa (AN) patients into restricting and binge-eating/purging types has demonstrated limited predictive validity. This study aimed to evaluate whether an approach to classifying eating disorder patients on the basis of comorbid personality psychopathology has utility in predicting treatment response and readmission in patients with AN.

Method: Data were collected from 154 AN patients (M [SD] age = 25.

View Article and Find Full Text PDF

Monitoring and managing weight gain in the mentally ill.

J Clin Psychiatry

June 2007

Department of Psychiatry, University of Pittsburgh School of Medicine and Western Psychiatric Institute and Clinic, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.

View Article and Find Full Text PDF

Objective: Few data are available concerning the utility of augmentation in late-life depression treatment. The authors examined likelihood, speed, and predictors of recovery in older adults receiving augmentation pharmacotherapy after inadequate response to standardized treatment with paroxetine plus interpersonal psychotherapy.

Method: Depression levels were monitored during open treatment in 195 adults age 70 or older.

View Article and Find Full Text PDF

Objective: Olanzapine, an atypical antipsychotic, has been shown to be efficacious for treatment of psychotic and mood disorders in adults. This prospective, open-label study was conducted to examine the safety and usefulness of olanzapine in treating disruptive behavior disorders in adolescents with subaverage intelligence.

Method: Sixteen adolescents (ages 13-17 years) with borderline to moderate mental retardation and disruptive behavior were enrolled in an 8-week olanzapine trial (5-20 mg/day).

View Article and Find Full Text PDF

Contextual emotion-regulation therapy for childhood depression: description and pilot testing of a new intervention.

J Am Acad Child Adolesc Psychiatry

August 2006

Dr. Kovacs and Tumuluru are with the Department of Psychiatry, University of Pittsburgh School of Medicine and Western Psychiatric Institute and clinic, Pittsburgh; Dr. Sherrill is with the National Institute of Mental Health, Bethesda; Mr. George and Ms. Pollock are with the University of Pittsburgh Medical Center, Dr. Ho is with CYKE, Inc., Atlanta.

Objective: To pilot test the acceptability and efficacy of contextual emotion-regulation therapy (CERT), a new, developmentally appropriate intervention for childhood depression, which focuses on the self-regulation of dysphoria.

Method: Two samples of convenience (n = 29, n = 2) served to verify some CERT constructs; it was then operationalized in a treatment manual. To pilot test CERT, 20 children (ages 7-12; 35% girls) with DSM dysthymic disorder (mean duration 24.

View Article and Find Full Text PDF

Objective: Evidence concerning whether sleep disturbances in older adults predict mortality is mixed. However, data are limited to self-reported sleep problems and may be confounded with other comorbidities. We examined whether electroencephalographic (EEG) sleep parameters predicted survival time independently of known predictors of all-cause mortality.

View Article and Find Full Text PDF

This study reports the outcome of a 1-year follow-up study of 37 patients with a delusional depression treated with electroconvulsive therapy (ECT). Thirty-two (86%) of the patients initially responded to ECT. However, 16 (50%) of the 32 responders relapsed within 1 year.

View Article and Find Full Text PDF